Ignite Creation Date:
2025-12-25 @ 4:06 AM
Ignite Modification Date:
2026-01-29 @ 12:37 AM
Study NCT ID:
NCT06453902
Status:
RECRUITING
Last Update Posted:
2025-02-21
First Post:
2024-05-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
TGRX-678 Chinese Phase II in Chronic Myelogenous Leukemia (CML) Patients
Sponsor:
Organization: